In vitro Metabolomic Approaches to Investigating the Potential Biological Effects of Phenolic Compounds: An Update

Úrsula Catalán1, Laura Barrubés1, Rosa Maria Valls1

  • 1Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Technological Center of Nutrition and Health (CTNS), Institut d'Investigació Sanitària Pere Virgili (IISPV), Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, Reus 43201, Spain.

Insights

Dietary phenolic compounds (PCs) show potential in disease prevention by influencing cellular metabolism. Further in vitro metabolomic studies are needed to fully understand their molecular mechanisms and health benefits.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nutritional Science

Background:

  • Dietary phenolic compounds (PCs) are investigated for disease prevention.
  • Understanding the molecular mechanisms of PCs requires further research.
  • In vitro metabolomic approaches offer a way to study cellular responses to PCs.

Purpose of the Study:

  • To review and analyze existing in vitro metabolomic studies on dietary PCs.
  • To explore the molecular mechanisms underlying the biological effects of PCs.
  • To identify potential clinical impacts of PCs on various diseases.

Main Methods:

  • Systematic review of in vitro metabolomic studies involving PCs.
  • Analysis of cell-based metabolomic data following PC exposure.
  • Integration of findings with transcriptomic and proteomic data where available.

Main Results:

  • PCs modulate basic cellular processes and nutrient metabolism.
  • Specific metabolic pathways influenced by PCs were identified.
  • These pathways have potential clinical relevance for neurodegenerative diseases, type 2 diabetes, cancer, and cardiovascular diseases.

Conclusions:

  • In vitro metabolomic studies provide valuable insights into the molecular mechanisms of dietary PCs.
  • Further cell-based metabolomic research is essential to elucidate PC mechanisms.
  • Investigating physiological conjugated forms of PCs in vitro is a promising future direction.

Related Concept Videos

Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
68
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
836
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.3K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
53